October 11th 2024
The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024.
October 4th 2024
The agency is working with the European medicines regulatory network to improve the assessment and approval process for new medications.
September 24th 2024
Approvals were recommended for treatments of ovarian cancer, lung cancer, bleeding disorders, respiratory disease, and more.
September 23rd 2024
The agency is recommending the extension of the smallpox and mpox vaccine, Imvanex, to adolescents aged 12 to 17.
June 18th 2024
The agency is evaluating risks associated with the painkiller metamizole. It is also reviewing the risk of secondary malignancies in patients treated with CAR T-cell medicines.